晚期肾细胞癌过继性细胞免疫治疗的疗效、安全性和临床格局：系统综述和 meta 分析

Efficacy, safety, and clinical landscape of adoptive cell immunotherapy in advanced renal cell carcinoma: A systematic review and meta-analysis.

ACI 在晚期 RCC 中显示出有限的疗效和良好的安全性，尤其是在联合治疗策略中。需要进一步开展大规模、设计良好的试验来确认长期获益。

NK 细胞治疗实体瘤患者的疗效与安全性：一项系统综述与荟萃分析

Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis.

NK 细胞疗法是实体瘤有前景的治疗选择，为 CAR-T 等基因修饰细胞疗法提供了可行的替代方案。

靶向肠道菌群以增强 CAR-T 细胞治疗的抗肿瘤疗效并减轻毒性：新希望？

Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?

靶向抑制 Nrf2 增强抗肿瘤免疫并提高肝细胞癌免疫治疗疗效

Targeted inhibition of Nrf2 potentiates antitumor immunity and enhances the efficacy of immunotherapy in hepatocellular carcinoma.

我们的发现提供了一种通过阻断 Nrf2 来增强 HCC 免疫治疗的新策略，这有可能解决当前 HCC 免疫治疗中观察到的低响应率问题。

最大化 CAR-T 细胞免疫治疗肿瘤疗效的输注与递送策略

Infusion and delivery strategies to maximize the efficacy of CAR-T cell immunotherapy for cancers.

下一代肿瘤治疗：光免疫疗法在不可切除头颈部肿瘤中的前景

Next-Generation Cancer Treatment: Photoimmunotherapy's Promise for Unresectable Head and Neck Cancers.

重新定义结直肠癌之战：新兴免疫疗法及其临床疗效的综合综述

Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.

增强 CAR-T 细胞治疗的疗效：细胞策略与分子动力学的全面探索

Enhancing the Efficacy of CAR-T Cell Therapy: A Comprehensive Exploration of Cellular Strategies and Molecular Dynamics.

调控 VIP-VIPR 通路重编程 CAR-T 细胞以在临床前癌症模型中获得更优抗肿瘤疗效

Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models.

用于肝细胞癌的 GPC3 特异性 dnTGFβRII 装甲 CAR-T 细胞

GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma.